Funding · Healthcare & Life Sciences
Rymo Technologies raises ₹10 crore seed funding
By Startup Enthusiast ·
- Date
- Company
- Rymo Technologies
- What it does
- Robotic neuro-rehabilitation devices
- Kind
- Funding
- Amount
- ₹10 Cr
- Stage
- seed
- Based in
- Navi Mumbai
- Founded
- 2020
What they do
Rymo Technologies makes robotic systems for neuro-rehabilitation with AI therapy personalisation
What happened
It raised over ₹10 crore in seed funding led by IAN Angel Fund
Why it matters
The company has installed over 452 devices and served more than 7,500 patients
The details
- Rymo Technologies raised over ₹10 crore in seed funding.
- The round was led by IAN Angel Fund, the evergreen fund of the IAN Group.
- Other angel investors also participated in the round.
- The company will use the funds to accelerate product innovation and expand manufacturing.
- It also plans to strengthen its presence in India and scale into ASEAN and the Middle East.
- Rymo has a distribution partnership with Fourier Rehab for ASEAN markets.
The bigger picture
- The global neuro-rehabilitation devices market is valued at about $2.16 billion and growing roughly 14% annually.
- Rymo's devices have shown up to 25% faster recovery outcomes per studies.
- The company has received US FDA Class II medical device classification.
- A clinical validation study is underway in Italy.
About the business
- Rymo Technologies is a robotic neuro-rehabilitation startup headquartered in Navi Mumbai, India.
- Its product is a multi-joint robotic rehabilitation system with AI-driven therapy personalisation.
- The flagship product is the Mobi-L system.
- Target customers include mid-sized hospitals and physiotherapy clinics in Tier 1 and Tier 2 cities.
- It has installed over 452 devices across 354 clinical customers, including AIIMS, Apollo Hospitals, and Manipal Hospitals.
- The platform has supported over 7,500 patients and delivered over 15,000 therapy hours.
What happens next
- Accelerate product innovation.
- Expand manufacturing capabilities.
- Strengthen India presence.
- Scale into ASEAN and Middle East markets.
The deal
- Type
- seed
Investors
- IAN Angel Fund (lead) — Evergreen fund of the IAN Group.
Founders
- Chirag Shah, CEO
- Abhishek Rai, CTO
About Rymo Technologies
- Product
- Robotic neuro-rehabilitation systems including flagship Mobi-L device with VR integration for post-stroke and neurological recovery
- Customers
- Patients recovering from strokes, injuries and neurological conditions; rehabilitation centers and hospitals
- How it makes money
- B2B2C medical device sales and installation with ongoing support
- What sets it apart
- Accessible and affordable advanced rehabilitation technology addressing gap in neuro-rehabilitation access
Other articles talking about it
Same day
- MobiKwik appoints Anis Pathan chief risk officer19 March 2026 · People
- WeRize reports doubled profit and revenue growth in FY2519 March 2026 · Results
- Jiraaf raises ₹44 crore extended Series B19 March 2026 · Funding · ₹43.76 crore
- Tamil Nadu agency invests ₹25 Cr in Agnikul Cosmos19 March 2026 · Funding · ₹25 Cr
- Prime Video deepens India focus as market matures19 March 2026 · Analysis
- FinSight Ventures eyes more Indian fintech deals19 March 2026 · Analysis · $20 Mn